Cargando…

Clinical utility, safety, and tolerability of ezogabine (retigabine) in the treatment of epilepsy

One-third of patients with epilepsy continue to have seizures despite current treatments, indicating the need for better antiseizure medications with novel mechanisms of action. Ezogabine (retigabine) has recently been approved for adjunctive treatment of partial-onset seizures in adult patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ciliberto, Michael A, Weisenberg, Judith LZ, Wong, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2012
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3413039/ https://www.ncbi.nlm.nih.gov/pubmed/22888276 http://dx.doi.org/10.2147/DHPS.S28814

Ejemplares similares

Profile of ezogabine (retigabine) and its potential as an adjunctive treatment for patients with partial-onset seizures
por: Weisenberg, Judith LZ, et al.
Publicado: (2011)

Physician and Pharmacist Understanding of the Risk of Urinary Retention with Retigabine (Ezogabine): A REMS Assessment Survey
por: Ishihara, Lianna, et al.
Publicado: (2015)

Lack of effect of ezogabine/retigabine on the pharmacokinetics of digoxin in healthy individuals: results from a drug–drug interaction study
por: Tompson, Debra J, et al.
Publicado: (2014)

Clinical utility of adjunctive retigabine in partial onset seizures in adults
por: Rejdak, Konrad, et al.
Publicado: (2012)

Neuronal potassium channel openers in the management of epilepsy: role and potential of retigabine
por: Barrese, Vincenzo, et al.
Publicado: (2010)

New and Emerging Treatments for Epilepsy: Review of Clinical Studies of Lacosamide, Eslicarbazepine Acetate, Ezogabine, Rufinamide, Perampanel, and Electrical Stimulation Therapy
por: Chung, Steve S., et al.
Publicado: (2011)

Ezogabine skin discoloration is reversible after discontinuation
por: Mathias, Sally V., et al.
Publicado: (2017)

Efficacy of Retigabine in Adjunctive Treatment of Partial Onset Seizures in Adults
por: Splinter, Michele Y.
Publicado: (2013)

Electro-mechanical coupling of KCNQ channels is a target of epilepsy-associated mutations and retigabine
por: Yang, Nien-Du, et al.
Publicado: (2022)

KCNQ2 encephalopathy: Features, mutational hot spots, and ezogabine treatment of 11 patients
por: Millichap, John J., et al.
Publicado: (2016)

Investigation of the impact of urine handling procedures on interpretation of urinalysis findings and product safety in subjects treated with ezogabine
por: Brickel, Neil, et al.
Publicado: (2013)

Survey of Physicians’ Understanding of Specific Risks Associated with Retigabine
por: Daniluk, Jerzy, et al.
Publicado: (2016)

Efficacy of Retigabine on Acute Limbic Seizures in Adult Rats
por: Friedman, LK, et al.
Publicado: (2015)

European Survey of Prescriber Understanding of Risks Associated with Retigabine
por: Ishihara, Lianna, et al.
Publicado: (2015)

Beneficial effect of retigabine on memory in rats receiving ethanol
por: Zwierzyńska, Ewa, et al.
Publicado: (2020)

Effects of the KCNQ channel opener ezogabine on functional connectivity of the ventral striatum and clinical symptoms in patients with major depressive disorder
por: Tan, Aaron, et al.
Publicado: (2018)

The anticonvulsant retigabine is a subtype selective modulator of GABA (A) receptors
por: Treven, Marco, et al.
Publicado: (2015)

The anticonvulsant retigabine suppresses neuronal K(V)2-mediated currents
por: Stas, Jeroen I., et al.
Publicado: (2016)

Molecular Insights Into Binding and Activation of the Human KCNQ2 Channel by Retigabine
por: Garofalo, Barbara, et al.
Publicado: (2022)

Retigabine suppresses loss of force in mouse models of hypokalaemic periodic paralysis
por: Quiñonez, Marbella, et al.
Publicado: (2023)

Study of gender-related pharmacokinetics of ezogabine in Egyptian volunteers by a validated LC-MS/MS bioanalytical method
por: Elkady, Ehab F., et al.
Publicado: (2019)

Acute retigabine‐induced effects on myelinated motor axons in amyotrophic lateral sclerosis
por: Sleutjes, Boudewijn T. H. M., et al.
Publicado: (2022)

Retigabine holds K(V)7 channels open and stabilizes the resting potential
por: Corbin-Leftwich, Aaron, et al.
Publicado: (2016)

One drug-sensitive subunit is sufficient for a near-maximal retigabine effect in KCNQ channels
por: Yau, Michael C., et al.
Publicado: (2018)

A case report: retigabine induced oral mucosal dyspigmentation of the hard palate
por: Beacher, Nicholas G., et al.
Publicado: (2015)

Modifications of the Triaminoaryl Metabophore of Flupirtine and Retigabine Aimed at Avoiding Quinone Diimine Formation
por: Wurm, Konrad W., et al.
Publicado: (2022)

A Comment on Craig et al.: ‘‘Retigabine for the Adjunctive Treatment of Adults with Partial-Onset Seizures in Epilepsy with and without Secondary Generalization: A NICE Single Technology Appraisal’’
por: Holko, Przemysław, et al.
Publicado: (2013)

Pharmacokinetics of XEN496, a Novel Pediatric Formulation of Ezogabine, Under Fed and Fasted Conditions: A Phase 1 Trial
por: Namdari, Rostam, et al.
Publicado: (2022)

Liquid chromatographic methods for determination of the new antiepileptic drugs stiripentol, retigabine, rufinamide and perampanel: A comprehensive and critical review
por: Meirinho, Sara, et al.
Publicado: (2021)

Carba Analogues of Flupirtine and Retigabine with Improved Oxidation Resistance and Reduced Risk of Quinoid Metabolite Formation
por: Wurm, Konrad W., et al.
Publicado: (2022)

Combining endocannabinoids with retigabine for enhanced M-channel effect and improved K(V)7 subtype selectivity
por: Larsson, Johan E., et al.
Publicado: (2020)

Safety and tolerability of denosumab for the treatment of postmenopausal osteoporosis
por: Lewiecki, E Michael
Publicado: (2011)

The Effects of the KCNQ Openers Retigabine and Flupirtine on Myotonia in Mammalian Skeletal Muscle Induced by a Chloride Channel Blocker
por: Su, Tzu-Rong, et al.
Publicado: (2012)

The Kv7 channel activator, retigabine, induces vasorelaxation via an endothelial-independent pathway in male mouse aorta
por: Namgoong, Hyun, et al.
Publicado: (2018)

Brain stimulation treatments in epilepsy: Basic mechanisms and clinical advances
por: Foutz, Thomas J., et al.
Publicado: (2022)

Clinical utility, safety, and efficacy of pregabalin in the treatment of fibromyalgia
por: Bhusal, Santosh, et al.
Publicado: (2016)

Activation of voltage-gated KCNQ/Kv7 channels by anticonvulsant retigabine attenuates mechanical allodynia of inflammatory temporomandibular joint in rats
por: Xu, Wen, et al.
Publicado: (2010)

The Utility of Responsive Neurostimulation for the Treatment of Pediatric Drug-Resistant Epilepsy
por: Piazza, Martin G., et al.
Publicado: (2023)

Clinical utility and tolerability of linagliptin in diabetic patients
por: Maxwell, Lauralee Gordon, et al.
Publicado: (2013)

Safety, Tolerability, and Immunogenicity of Interferons
por: Tovey, Michael G., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_lkg9t5oh5lr19aapir9qgcbo17